Cited by 2,834Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

The Crisis in Antibiotic Resistance

Neu, Harold C.·1992·Science

Open this paper in CoChat — free account

Abstract

The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.

Integrity signals

Registry

Crossref · 10.1126/science.257.5073.1064

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593

Show all 109 references

Research works printed but not linked: 30

AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
Fisher, M., New Antibacterial Strategies 177 (1990).
Higgins, C. F., New Antibacterial Strategies 193 (1990).
KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
Mitsuhashi, S., The Aminoglycosides 97 (1982).
MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
Neu, H. C., Human Pharmacology 613 (1991).
Normark, S., New Antibacterial Strategies 161 (1990).
PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).

Sorted by citations

Items 101–200 of 1,000

Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing
Bae, T., Banger, A. K., Wallace, A., Glass, E. M., Åslund, F., Schneewind, O., & Missiakas, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404728101 · Cited by 322
The Population Genetics of Antibiotic Resistance
Levin, B. R., Lipsitch, M., Perrot, V., Schrag, S. J., Antia, R., Simonsen, L., Walker, N., & Stewart, F. M. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s9 · Cited by 315
“At this point, it seems unlikely that the antibiotics with waning efficacy because of resistance will be replaced at an adequate rate to compensate for their loss from our arsenal [24].”
Background
Non-antibiotic pharmaceuticals enhance the transmission of exogenous antibiotic resistance genes through bacterial transformation
Wang, Y., Lu, J., Engelstädter, J., Zhang, S., Ding, P., Mao, L., Yuan, Z., Bond, P. L., & Guo, J. (2020) · The ISME Journal · doi:10.1038/s41396-020-0679-2 · Cited by 305
Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure
Knox, J. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2593 · Cited by 312
“In the last decade the usefulness of the oximino-b-lactams and monobactams has been compromised by the increasing presence of clinically derived extended-spectrum b-lactamases (10, 16, 40, 41, 53, 65, 74).”
Background
Mode of Action of Bi- and Trinuclear Zinc Hydrolases and Their Synthetic Analogues
Weston, J. (2005) · Chemical Reviews · doi:10.1021/cr020057z · Cited by 311
Synthesis of fluorescent D-amino acids and their use for probing peptidoglycan synthesis and bacterial growth in situ
Kuru, E., Tekkam, S., Hall, E. A., Brun, Y. V., & VanNieuwenhze, M. S. (2014) · Nature Protocols · doi:10.1038/nprot.2014.197 · Cited by 311
“HADA (3) and NADA (5), which are currently the most robust DAA derivatives, can be prepared in good yields from N- -Boc–protected 3-aminod-alanine (1), via nucleophilic capture of an activated ester of 7-hydroxycoumarin-3-carboxylic acid (HCC-OH; 2) or by nucleophilic aromatic substitution of 4-chloro-7-nitrobenzo2-ox…”
Antifungal drug resistance to azoles and polyenes
Canuto, M. M., & Rodero, F. G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00371-7 · Cited by 310
Antimicrobial and Antifouling Strategies for Polymeric Medical Devices
Zander, Z. K., & Becker, M. L. (2017) · ACS Macro Letters · doi:10.1021/acsmacrolett.7b00879 · Cited by 312
The Complex Relationship between Virulence and Antibiotic Resistance
Schroeder, M., Brooks, B. D., & Brooks, A. E. (2017) · Genes · doi:10.3390/genes8010039 · Cited by 326
Resilience: A Literature Review
Martin-Breen, P., & Anderies, J. M. (2011) · OpenDocs (Institute of Development Studies) · Cited by 302
Study on the mechanism of antibacterial action of magnesium oxide nanoparticles against foodborne pathogens
He, Y., SHAKUNTALA, I., Reed, S., Gehring, A., Strobaugh, T. P., & Irwin, P. L. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0202-0 · Cited by 312
“The sporadic prevalence of microbial pathogens in food and increased incidence of antibiotic resistant strains have posed serious concerns to public health [6, 7].”
Background
Antibacterial Liquid Metals: Biofilm Treatment via Magnetic Activation
Elbourne, A., Cheeseman, S., Atkin, P., Truong, N. P., Syed, N., Zavabeti, A., Mohiuddin, M., Esrafilzadeh, D., Cozzolino, D., McConville, C. F., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b07861 · Cited by 302
BOCILLIN FL, a Sensitive and Commercially Available Reagent for Detection of Penicillin-Binding Proteins
Zhao, G., Meier, T. I., Kahl, S. D., Gee, K. R., & Blaszczak, L. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1124 · Cited by 301
“Resistance to b-lactam antibiotics in some species such as Streptococcus pneumoniae has occurred by development of altered high-molecular-mass PBPs which have reduced affinity for the antibiotics (6, 7, 10, 11, 14, 24, 25, 29, 30).”
Background
Coselection for microbial resistance to metals and antibiotics in freshwater microcosms
Stepanauskas, R., Glenn, T. C., Jagoe, C. H., Tuckfield, R. C., Lindell, A. H., King, C. J., & McArthur, J. V. (2006) · Environmental Microbiology · doi:10.1111/j.1462-2920.2006.01091.x · Cited by 305
“While the use of antibiotics in medicine and agriculture clearly stimulates the proliferation of antibiotic resistance (Neu, 1992), heavy metals and other toxicants have also been suggested to play an important role (Summers, 2002).”
Background
Small molecule control of bacterial biofilms
Worthington, R. J., Richards, J. J., & Melander, C. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25835h · Cited by 303
Bacterial resistance to antimicrobial agents used in fish farming: A critical evaluation of method and meaning
Smith, P. R., Hiney, M. P., & Samuelsen, O. B. (1994) · Annual Review of Fish Diseases · doi:10.1016/0959-8030(94)90032-9 · Cited by 298
New Directions in Antibacterial Research
Chu, D. T. W., Plattner, J. J., & Katz, L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960294s · Cited by 298
Bacterial Resistance to Antimicrobial Agents
Varela, M. F., Stephen, J., Lekshmi, M., Ojha, M., Wenzel, N., Sanford, L. M., Hernandez, A. J., Parvathi, A., & Kumar, S. H. (2021) · Antibiotics · doi:10.3390/antibiotics10050593 · Cited by 322
“Such pathogenic bacteria produce alarming numbers in terms of morbidity and mortality outcomes [2,3].”
Background
Phylogenetic Characterization of Virulence and Resistance Phenotypes of Pseudomonas syringae
Hwang, M. S. H., Morgan, R. L., Sarkar, S. F., Wang, P. W., & Guttman, D. S. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.9.5182-5191.2005 · Cited by 292
“syringae strains also come into contact with medically important antibiotics, and their associated resistance genes, that spread in the natural environment (37).”
Background
Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic
van Wageningen, A. M. A., Kirkpatrick, P. N., Williams, D. H., Harris, B. R., Kershaw, J. K., Lennard, N. J., Jones, M. R., Jones, S. J. M., & Solenberg, P. J. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90060-6 · Cited by 289
Silica Nanopollens Enhance Adhesion for Long-Term Bacterial Inhibition
Song, H., Nor, Y. A., Yu, M., Yang, Y., Zhang, J., Zhang, H., Xu, C., Mitter, N., & Yu, C. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b00243 · Cited by 289
Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development
Hiroshi Yoneyama, C., & Katsumata, R. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70.1060 · Cited by 284
Role of reactive oxygen species in the antibacterial mechanism of silver nanoparticles on Escherichia coli O157:H7
Xu, H., Qu, F., Xu, H. T., Lai, W., Wang, Y. A., Aguilar, Z. P., & Wei, H. (2011) · BioMetals · doi:10.1007/s10534-011-9482-x · Cited by 285
“changes or the exchange of genetic material via plasmids and transposons (Neu 1992).”
BackgroundInfluential
Microarray-Based Detection of 90 Antibiotic Resistance Genes of Gram-Positive Bacteria
Perreten, V., Vorlet-Fawer, L., Slickers, P., Ehricht, R., Kuhnert, P., & Joachim Frey, A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2291-2302.2005 · Cited by 280
“The intensive use of antibiotics in both public health and animal husbandry has selected for antibiotic-resistant bacteria (39).”
Background
Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999
Steinman, M. A., Gonzales, R., Linder, J. A., & Landefeld, C. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00008 · Cited by 274
“As a result, the medical profession risks losing some of its most potent therapies for patients with the greatest need (38).”
Background
The continuing crisis in antibiotic resistance
French, G. L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(10)70003-0 · Cited by 276
“Nevertheless, continuing misuse of antibiotics and poor hygienic practice had produced such serious problems by the early 1990s that several authorities were prompted to publish serious warnings of impending catastrophe in major international journals, with titles such as: ‘The crisis in antibiotic resistance’ [41], ‘…”
Background
Application of Struvite Alters the Antibiotic Resistome in Soil, Rhizosphere, and Phyllosphere
Chen, Q., An, X., Zhu, Y., Su, J.-Q., Gillings, M. R., Ye, Z., & Li, C. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b01420 · Cited by 273
Antimicrobial Efficacy of Riboflavin/UVA Combination (365 nm) In Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious Keratitis
Martins, S. A. R., Castro-Combs, J., Noguera, G. E., Camacho, W., Wittmann, P., Walther, R., Cano, M., Dick, J. D., & Behrens, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1592 · Cited by 271
“Microbes cleverly develop resistance to antibiotics as a result of chromosomal mutation, inductive expression of a latent chromosomal genes, or exchange of genetic material via transformation, bacteriophage transduction, or plasmid conjugation.(1,4) Use of the fluoroquinolones in the management of external infections…”
Background
Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure
Chandler, C. (2019) · Humanities and Social Sciences Communications · doi:10.1057/s41599-019-0263-4 · Cited by 285
“When an antibiotic is unable to act upon a bacteria because of that organism’s physical characteristics, this is also termed resistance, this time ‘intrinsic’ (Neu, 1992).”
Background
Parent Resistance to Physicians' Treatment Recommendations: One Resource for Initiating a Negotiation of the Treatment Decision
Stivers, T. (2005) · Health Communication · doi:10.1207/s15327027hc1801_3 · Cited by 283
“…faces a large-scale problem with antibiotic-resistant bacteria (e.g., Baquero, Baquero-Artigao, Canton, & Garcia-Rey, 2002; McCaig & Hughes, 1995; Neu, 1992; Whitney et al., 2000; Wise et al., 1998), inappropriate prescribing of antibiotics for viral infections remains common (e.g., Finkelstein…”
Background
Reducing infections through nanotechnology and nanoparticles
Webster, T. J., & Taylor (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22021 · Cited by 270
“In fact, clinically relevant resistance to glycopeptides vancomycin and teicoplanin were reported in vancomycin-resistant enterococci (VRE) as early as 1992, through the plasmid-borne transferable gene VanA.”
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences.
Martin, R. G., & Rosner, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5456 · Cited by 265
Pathogen survival in the external environment and the evolution of virulence
Walther, B. A., & Ewald, P. W. (2004) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793104006475 · Cited by 261
A Highly Efficient TiO2–xCx Nano-heterojunction Photocatalyst for Visible Light Induced Antibacterial Applications
Etacheri, V., Michlits, G., Seery, M. K., Hinder, S. J., & Pillai, S. C. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am302676a · Cited by 264
Sorption of sulfamethazine onto different types of microplastics: A combined experimental and molecular dynamics simulation study
Guo, X., Liu, Y., & Wang, J. (2019) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2019.06.063 · Cited by 263
Combating medical device fouling
Harding, J. L., & Reynolds, M. M. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.12.004 · Cited by 269
Synthetic Ligand-Coated Magnetic Nanoparticles for Microfluidic Bacterial Separation from Blood
Lee, J., Jeong, K. J., Hashimoto, M., Kwon, A. H., Rwei, A. Y., Shankarappa, S. A., Tsui, J. H., & Kohane, D. S. (2013) · Nano Letters · doi:10.1021/nl3047305 · Cited by 256
Spread of Drug‐ResistantStreptococcus pneumoniaein Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study
Song, J., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C., Lalitha, M. K., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514783 · Cited by 258
Antibiotic Resistance: Consequences of Inaction
Levy, S. B. (2001) · Clinical Infectious Diseases · doi:10.1086/321837 · Cited by 257
“Bacterial resistance, which began an emerging problem, has grown to be a crisis [1].”
Background
Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities
Saberwal, G., & Nagaraj, R. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(94)90002-7 · Cited by 255
Spread of antibiotic resistance with food-borne pathogens
Teuber, M. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050022 · Cited by 253
The current status of natural products from marine fungi and their potential as anti-infective agents
Bhadury, P., Mohammad, B. T., & Wright, P. C. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-005-0070-3 · Cited by 250
“methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus), which are causing serious problems in the containment of infectious diseases [32, 42, 74, 114, 120, 147, 164].”
Background
Visible-light-driven photocatalytic degradation of ofloxacin by g-C3N4/NH2-MIL-88B(Fe) heterostructure: Mechanisms, DFT calculation, degradation pathway and toxicity evolution
Su, Q., Li, J., Yuan, H., Wang, B., Wang, Y., Li, Y., & Xing, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131594 · Cited by 252
Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods
Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00013 · Cited by 252
“Whenever possible, only studies that enrolled consecutive, nonreferral ambulatory patient populations were considtion and selection of evidence; (2) explicit identification of management options and outcomes; ( 3 ) evaluation and rating of the quality of the evidence; and (4) incorporation of practice guideline elemen…”
Background
RNA Sequence Determinants for Aminoglycoside Binding to an A-site rRNA Model Oligonucleotide
Recht, M. I., Fourmy, D., Blanchard, S. C., Dahlquist, K. D., & Puglisi, J. D. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0526 · Cited by 252
“Organisms have developed resistance to antibiotics by three major mechanisms: enzymatic modification and inactivation of antibiotics, altering the target of the antibiotics, or active efflux of antibiotics from the cell (Neu, 1992).”
Background
Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates
Summers, A. O., Wireman, J., Vimy, M. J., Lorscheider, F. L., Marshall, B. M., Levy, S. B., Bennett, S., & Billard, L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.825 · Cited by 249
“This hypothesis is of more than just academic interest; the rising incidence of multiple antibiotic resistances in pathogens is a major problem in medicine (8, 25).”
Background
Empirical antibacterial drug discovery—Foundation in natural products
Singh, S. B., & Barrett, J. F. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.016 · Cited by 262
“After a number of years of use, emergence of nosocomial vancomycin-resistant Staphylococcus aureus and Enterococcus faecalis strains have become a common occurrence [12,13].”
Background
Horizontal gene transfer from transgenic plants to terrestrial bacteria – a rare event?
Nielsen, K. M., Bones, A. M., Smalla, K., & van Elsas, J. D. (1998) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1998.tb00362.x · Cited by 242
“[214] Neu, H.”
Active use of the metapleural glands by ants in controlling fungal infection
Fernández‐Marín, H., Zimmerman, J. K., Rehner, S. A., & Wcislo, W. T. (2006) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2006.3492 · Cited by 240
“Insect societies have confronted and solved problems that are analogous to the major public-health challenges that humans face in controlling infectious diseases and their resistance to antimicrobial compounds (Cohen 1992; Neu 1992).”
BackgroundInfluential
Antibacterial activities with the structure-activity relationship of coumarin derivatives
Qin, H., Zhang, Z.-W., Lekkala, R., & Rakesh, K. P. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112832 · Cited by 240
Resistance responses of microorganisms in food environments
Bower, C. I. (1999) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(99)00075-6 · Cited by 235
Antibacterial mechanisms and applications of metal-organic frameworks and their derived nanomaterials
Liu, J., Wu, D., Zhu, N., Wu, Y., & Li, G. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.01.012 · Cited by 237
Andrographis paniculatain the Treatment of Upper Respiratory Tract Infections: A Systematic Review of Safety and Efficacy
Coon, J. T., & Ernst, E. K. (2004) · Planta Medica · doi:10.1055/s-2004-818938 · Cited by 232
Hospital-acquired infections: diseases with increasingly limited therapies.
Swartz, M. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2420 · Cited by 232
Antibacterial Household Products: Cause for Concern
Levy, S. B. (2001) · Emerging infectious diseases · doi:10.3201/eid0707.017705 · Cited by 231
“However, after years of overuse and misuse of these drugs, bacteria have developed antibiotic resistance, which has become a global health crisis (1, 2).”
Background
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S. L., Bai, G. H., Suffys, P. N., Portillo-Gómez, L., Fairchok, M. P., & Rouse, D. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 229
“Reduced sensitivity to streptomycin in bacteria can occur because of the synthesis of aminoglycoside-modifying proteins, which are usually encoded on plasmids and transposons [26].”
Background
Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,4-triazole derivatives
Turan‐Zitouni, G., Kaplancıklı, Z. A., Yıldız, M. T., Chevallet, P., & Kaya, D. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.01.007 · Cited by 231
Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria
Stojiljkovic, I., Kumar, V., & Srinivasan, N. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01175.x · Cited by 230
“Patients infected with multiple resistant bacteria have more severe clinical courses and require prolonged hospital treatments, which are estimated to cost between $4 and $30 billion a year in the United States (Haley, 1986; Phelps, 1989; Neu, 1992).”
Background
Clubbed [1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis
Gill, C. H., Jadhav, G. R., Shaikh, M., Kale, R. P., Ghawalkar, A. R., Nagargoje, D. R., & Shiradkar, M. R. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.096 · Cited by 230
Antimicrobial properties of porphyrins
Stojiljković, I., Evavold, B., & Kumar, V. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.309 · Cited by 221
“The ‘epidemic of microbial resistance’ has seriously complicated treatment of bacterial infections by making many widely used drugs almost obsolete [51].”
Background
Performance of broilers fed diets supplemented with dry peppermint (Mentha piperita L.) or thyme (Thymus vulgaris L.) leaves as growth promoter source
Ocak, N., Erener, G., Ak, F. B., Sungu, M., Altop, A., & Ozmen, A. (2008) · Czech Journal of Animal Science · doi:10.17221/373-cjas · Cited by 231
“Recently most of the antibacterial performance promoters have been banned because the feeding of antibiotics is risky (Neu, 1992) due to not only cross-resistance but also to multiple resistances.”
Background
The evolving response to antibiotic resistance (1945–2018)
Podolsky, S. H. (2018) · Humanities and Social Sciences Communications · doi:10.1057/s41599-018-0181-x · Cited by 229
“Antibiotics paved the way for unprecedented medical and societal developments, and are today indispensible in all health systems.”
BackgroundInfluential
International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia
Rello, J., Paiva, J. A., Baraibar, J., Barcenilla, F., Bodí, M. A., Castander, D., Correa, H., Dı́az, E., Garnacho, J., Llorio, M., et al. (2001) · CHEST Journal · doi:10.1378/chest.120.3.955 · Cited by 229
Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids
Chao, H. X., Artemova, T., Gore, J., Yurtsev, E. A., & Datta, M. S. (2013) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 229
Structure and function of “metalloantibiotics”
Ming, L. (2003) · Medicinal Research Reviews · doi:10.1002/med.10052 · Cited by 231
Bacteria-Responsive Biomimetic Selenium Nanosystem for Multidrug-Resistant Bacterial Infection Detection and Inhibition
Lin, A., Liu, Y., Zhu, X., Chen, X., Liu, J., Zhou, Y., Qin, X., & Liu, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b05766 · Cited by 227
In Vivo Characterization of the Drug Resistance Profile of the Major ABC Transporters and Other Components of the Yeast Pleiotropic Drug Resistance Network
Kołaczkowski, M., Kołaczkowska, A., Łuczyński, J., Witek, S., & Goffeau, A. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.143 · Cited by 225
“…to the decades has led to the outbreak of life-threatening drug-re-ubiquitous superfamily of ABC transporters.26 The two ABC-sistant pathogens.54 .47,55,57 prom me clinical view, the most im-spread among immunocompromised patients.64 '68'69'70 This *Unite de Biochimie Physiologique,…”
Spatial dynamics of ecological public goods
Wakano, J. Y., Nowak, M. A., & Hauert, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812644106 · Cited by 220
“This is particularly evident in microbial systems involving extracellular products such as in antibiotic resistance (11, 13, 14), biofilms (10), or swarming (12) and represent crucial determinants of microbial ecology (40).”
Background
Vancomycin Resistance: Structure of D-Alanine:D-Alanine Ligase at 2.3 Å Resolution
Fan, C., Moews, P. C., Walsh, C. T., & Knox, J. R. (1994) · Science · doi:10.1126/science.7939684 · Cited by 226
Recombinant bacteriophage lysins as antibacterials
Fenton, M., McAuliffe, O. E., O’Mahony, J., & Coffey, A. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.1.9818 · Cited by 225
“There is currently an ever-growing concern over the global spread of antibiotic resistance among human and animal pathogens and the need for novel effective antibacterials (like phage lysins) to combat them is well recognised.(23,24) MRSA is now the most commonly reported antibiotic resistant bacterium in clinical set…”
Background
Stochastic Evolutionary Game Dynamics
Traulsen, A., & Hauert, C. (2009) · Wiley eBooks · doi:10.1002/9783527628001.ch2 · Cited by 229
The multi-faceted mechano-bactericidal mechanism of nanostructured surfaces
Ivanova, E. P., Linklater, D. P., Werner, M., Baulin, V. A., Xu, X., Vrancken, N., Rubanov, S., Hanssen, E. G., Wandiyanto, J. V., Truong, V. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916680117 · Cited by 224
A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses
Willcox, M. D. P., Hume, E. B. H., Aliwarga, Y., Kumar, N., & Cole, N. (2008) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03942.x · Cited by 223
“However, in many cases development of microbial resistance (Neu 1992) makes these forms of therapy short-lived.”
Background
Antimicrobial resistance: a global response.
Smith, R., & Coast, J. (2002) · Europe PMC (PubMed Central) · Cited by 222
Medical Outcomes and Antimicrobial Costs With the Use of the American Thoracic Society Guidelines for Outpatients With Community-Acquired Pneumonia
Gleason, P. P. (1997) · JAMA · doi:10.1001/jama.1997.03550010046038 · Cited by 222
Recurrent infections and immune evasion strategies of Staphylococcus aureus
Kim, H. K., Thammavongsa, V., Schneewind, O., & Missiakas, D. M. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.10.012 · Cited by 218
“aureus strains have evolved resistance against the most abundantly used therapeutics [3].”
Background
Nanomechanical detection of antibiotic–mucopeptide binding in a model for superbug drug resistance
Ndieyira, J. W., Watari, M., Barrera, A. D., Zhou, D., Vögtli, M., Batchelor, M. R., Cooper, M. A., Strunz, T., Horton, M. A., Abell, C., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.275 · Cited by 219
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens
Burrowes, B. H., Harper, D. R., Anderson, J., McConville, M., & Enright, M. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.90 · Cited by 218
Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms
Das, B., Verma, J., Kumar, P., Ghosh, A., & Ramamurthy, T. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.031 · Cited by 218
Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting
Said, D. G., Elalfy, M., Gatzioufas, Z., El-Zakzouk, E. S., Hassan, M., Saif, M., Zaki, A. A., Dua, H. S., & Hafezi, F. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.01.011 · Cited by 215
Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies
Dąbrowska, K., & Abedon, S. T. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-19 · Cited by 229
“(3, 4), phage therapy could potentially become more widespread as an antibacterial”
Background
A new synthesis of α-arylglycines from aryl boronic acids
Petasis, N. A., Goodman, A., & Zavialov, I. A. (1997) · Tetrahedron · doi:10.1016/s0040-4020(97)01028-4 · Cited by 213
Applications of Nonenzymatic Catalysts to the Alteration of Natural Products
Shugrue, C. R., & Miller, S. J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00022 · Cited by 212
A Survey of Knowledge, Attitudes, and Beliefs of House Staff Physicians From Various Specialties Concerning Antimicrobial Use and Resistance
Srinivasan, A., Song, X., Richards, A., Sinkowitz‐Cochran, R. L., Cardo, D. M., & Rand, C. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1451 · Cited by 211
Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000
McCaig, L. F., Besser, R. E., & Hughes, J. M. (2003) · Emerging infectious diseases · doi:10.3201/eid0904.020268 · Cited by 209
Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance
Kang, Y. K., Kwon, K., Ryu, J. S., Lee, H. N., Park, C., & Chung, H. J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00676 · Cited by 214
Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis
Kimura, K., & Bugg, T. D. H. (2003) · Natural Product Reports · doi:10.1039/b202149h · Cited by 208
Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review
Pareek, V., Gupta, R., & Panwar, J. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.093 · Cited by 208
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance Guidelines for the Prevention of Antimicrobial Resistance in Hospitals
Shlaes, D. M., Gerding, D. N., John, J. F., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/647610 · Cited by 206
Modern Trends in Aeromonas hydrophila Disease Management with Fish
Harikrishnan, R., & Balasundaram, C. (2005) · Reviews in Fisheries Science · doi:10.1080/10641260500320845 · Cited by 205
“Of all these strategies, prevention of disease is much more desirable than intervention to stop and reverse disease processes once they have begun (Neu, 1992).”
Background
The use of vancomycin and tobramycin in acrylic bone cement
Klekamp, J., Dawson, J. M., Haas, D. W., DeBoer, D. K., & Christie, M. (1999) · The Journal of Arthroplasty · doi:10.1016/s0883-5403(99)90061-x · Cited by 205
Aminoglycoside–RNA interactions
Walter, F., Vicens, Q., & Westhof, É. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00028-9 · Cited by 205
Host Resistance to Intracellular Infection: Mutation of Natural Resistance-associated Macrophage Protein 1 (Nramp1) Impairs Phagosomal Acidification
Hackam, D. J., Rotstein, O. D., Zhang, W.-J., Gruenheid, S., Gros, P., & Grinstein, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.351 · Cited by 202
“The widespread emergence of multidrug resistance in virtually all infectious diseases has increased the severity of the problem (5, 6).”
BackgroundMethod
Crystal structure of vancomycin
Schäfer, M., Schneider, T. R., & Sheldrick, G. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00156-6 · Cited by 204
“Clinically, vancomycin is often the last line of defence against deadly streptococcal and staphylococcal strains such as Staphylococcus aureus that have developed resistance to penicillin, methicillin and other b-lactam antibiotics [3,4].”
Background
Persistence of antibiotics such as macrolides, tiamulin and salinomycin in soil
Schlüsener, M. P., & Bester, K. (2006) · Environmental Pollution · doi:10.1016/j.envpol.2005.10.049 · Cited by 211
Factors in the Emergence of Infectious Diseases
Morse, S. S. (2001) · Palgrave Macmillan UK eBooks · doi:10.1057/9780230524248_2 · Cited by 201
Structure and function of the dihydropteroate synthase from staphylococcus aureus
Hampele, I. C., D'Arcy, A., Dale, G. E., Kostrewa, D., Nielsen, J., Oefner, C., Page, M. G. P., Schönfeld, H., Stüber, D., & Then, R. L. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0944 · Cited by 201
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber‐Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Springer eBooks · doi:10.1007/978-94-015-9702-9_15 · Cited by 200
“In the recent years bacteria highly resistant to most or all drug including antibiotic of last resort - vancomycin are spreading all over the world (6,7,10,12-15,27).”
Background
Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli
Brandish, P. E., Kimura, K., Inukai, M., Southgate, R., Lonsdale, J. T., & Bugg, T. D. H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1640 · Cited by 199
“The emergence of bacterial strains resistant to current antibiotics highlights the need to explore new targets for antibiotic action (15, 19).”
Background
Antibiotic Use for Emergency Department Patients With Upper Respiratory Infections: Prescribing Practices, Patient Expectations, and Patient Satisfaction
Ong, S., Nakase, J. Y., Moran, G. J., Karras, D. J., Kuehnert, M. J., & Talan, D. A. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.03.026 · Cited by 199
“The emergence of drug resistance has been closely linked to antibiotic use.(1,3,4,6,21,22) The significant incidence of adverse effects in patients given antibiotics inappropriately is also an important consideration.”
Background

Authors: Neu, H. C.
Affiliations: Columbia University (US)
Corresponding author: Neu, Harold C.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1992-08-21
Volume: 257
Issue: 5073
Pages: 1064-1073
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.257.5073.1064
OpenAlex: W1980595924
Cited by: 2,834
References: 109
Citations by year: 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
FWCI: 46.70
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
MeSH terms: Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Crisis in Antibiotic Resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks